financetom
Business
financetom
/
Business
/
Market Chatter: Meta Created Celebrity Chatbots Using Names, Likenesses Without Consent
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Meta Created Celebrity Chatbots Using Names, Likenesses Without Consent
Sep 2, 2025 4:29 AM

07:03 AM EDT, 09/02/2025 (MT Newswires) -- Meta (META) created chatbots using the names and likenesses of celebrities, including Taylor Swift, Scarlett Johansson, Anne Hathaway and Selena Gomez, without their permission, Reuters reported Saturday, citing internal data and testing.

While many bots were built by users with a Meta chatbot tool, a Meta employee reportedly produced at least three such avatars, including two labeled as Taylor Swift "parody" bots.

The publicly available bots on Facebook, Instagram, and WhatsApp often insisted they were the real celebrities and routinely made sexual advances or invited meet-ups, the news outlet reported.

Some adult chatbots produced inappropriate photorealistic images, many of which Meta deleted shortly before publication, and one bot generated similar pictures of underage actor Walker Scobell, Reuters reported.

The tools should not have created intimate images of adults or any pictures of child celebrities, and this is caused by enforcement failures, Reuters quoted Meta spokesman Andy Stone as saying.

Meta did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Philips Maintains Comparable Sales Growth View, to Install Azurion Systems in Indonesia; Shares up Pre-Bell
Philips Maintains Comparable Sales Growth View, to Install Azurion Systems in Indonesia; Shares up Pre-Bell
Jul 29, 2025
04:22 AM EDT, 07/29/2025 (MT Newswires) -- Royal Philips (PHG) said Tuesday it continues to expect comparable sales growth of 1% to 3% for the year. The company raised its full-year adjusted EBITA margin range to 11.3% to 11.8%, representing a 50-basis-point increase, compared with its prior guidance. Philips also said it is on track for its three-year, 2.5 billion-euro...
CenterPoint Energy Prices $900 Million Offering of Convertible Senior Notes
CenterPoint Energy Prices $900 Million Offering of Convertible Senior Notes
Jul 29, 2025
04:26 AM EDT, 07/29/2025 (MT Newswires) -- CenterPoint Energy ( CNP ) said late Monday it priced a $900 million offering of 3% convertible senior notes due 2028 in a private placement to institutional buyers. The company said it granted initial purchasers a 13-day option to purchase up to an additional $100 million of the notes. The company intends to...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Apellis Pharmaceuticals Says Kidney Disease Treatment Wins FDA Approval
Apellis Pharmaceuticals Says Kidney Disease Treatment Wins FDA Approval
Jul 29, 2025
04:20 AM EDT, 07/29/2025 (MT Newswires) -- Apellis Pharmaceuticals ( APLS ) said late Monday the US Food and Drug Administration has approved its Empaveli drug as the first treatment for kidney diseases C3 glomerulopathy or primary immune complex membranoproliferative glomerulonephritis in patients aged 12 years and older. The company said the approval was based on data from a phase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved